Need help finding what you are looking for?
Contact Us
PUBLISHER: GlobalData | PRODUCT CODE: 1396027
PUBLISHER: GlobalData | PRODUCT CODE: 1396027
Structural Heart Occluders Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
PUBLISHED:
PAGES: 104 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
Abstract
GlobalData's Medical Devices sector report, "Structural Heart Occluders Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" provides comprehensive information about the Structural Heart Occluders pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Structural heart occluders are used for treatment congenital heart defects by closing openings in the heart. Structural heart occluders covers left atrial appendage closure devices, atrial septal defect occluders, ventricular septal defect occluders, patent foramen ovale closure devices, patent ductus arteriosus closure devices.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Structural Heart Occluders under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Structural Heart Occluders and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Structural Heart Occluders under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
2 Introduction
- 2.1 Structural Heart Occluders Overview
3 Products under Development
- 3.1 Structural Heart Occluders - Pipeline Products by Stage of Development
- 3.2 Structural Heart Occluders - Pipeline Products by Segment
- 3.3 Structural Heart Occluders - Pipeline Products by Territory
- 3.4 Structural Heart Occluders - Pipeline Products by Regulatory Path
- 3.5 Structural Heart Occluders - Pipeline Products by Estimated Approval Date
- 3.6 Structural Heart Occluders - Ongoing Clinical Trials
4 Structural Heart Occluders - Pipeline Products under Development by Companies
- 4.1 Structural Heart Occluders Companies - Pipeline Products by Stage of Development
- 4.2 Structural Heart Occluders - Pipeline Products by Stage of Development
5 Structural Heart Occluders Companies and Product Overview
- 5.1 Abbott Japan Co Ltd Company Overview
- 5.1.1 Abbott Japan Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.2 Aegis Medical Innovations Inc. Company Overview
- 5.2.1 Aegis Medical Innovations Inc. Pipeline Products & Ongoing Clinical Trials Overview
- 5.3 Aporo Biomedical, Inc. (Inactive) Company Overview
- 5.3.1 Aporo Biomedical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
- 5.4 Append Medical Company Overview
- 5.4.1 Append Medical Pipeline Products & Ongoing Clinical Trials Overview
- 5.5 atHeart Medical Company Overview
- 5.5.1 atHeart Medical Pipeline Products & Ongoing Clinical Trials Overview
- 5.6 AuriGen Medical Ltd Company Overview
- 5.6.1 AuriGen Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.7 Boston Scientific Corp Company Overview
- 5.7.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
- 5.8 CARAG AG Company Overview
- 5.8.1 CARAG AG Pipeline Products & Ongoing Clinical Trials Overview
- 5.9 Cierra, Inc. (Inactive) Company Overview
- 5.9.1 Cierra, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
- 5.10 Conformal Medical Inc Company Overview
- 5.10.1 Conformal Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.11 Cor Habere Corp Company Overview
- 5.11.1 Cor Habere Corp Pipeline Products & Ongoing Clinical Trials Overview
- 5.12 Dextera Surgical Inc Company Overview
- 5.12.1 Dextera Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.13 Endomimetics LLC Company Overview
- 5.13.1 Endomimetics LLC Pipeline Products & Ongoing Clinical Trials Overview
- 5.14 Ension, Inc. Company Overview
- 5.14.1 Ension, Inc. Pipeline Products & Ongoing Clinical Trials Overview
- 5.15 Guangdong Pulse Medical Technology Co Ltd Company Overview
- 5.15.1 Guangdong Pulse Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.16 Hangzhou Dinova EP Technology Co Ltd Company Overview
- 5.16.1 Hangzhou Dinova EP Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.17 Hansen Medical Inc (Inactive) Company Overview
- 5.17.1 Hansen Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
- 5.18 Jenscare Scientific Co Ltd Company Overview
- 5.18.1 Jenscare Scientific Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.19 Laminar Inc Company Overview
- 5.19.1 Laminar Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.20 Lepu Scientech Medical Technology (Shanghai) Co Ltd Company Overview
- 5.20.1 Lepu Scientech Medical Technology (Shanghai) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.21 Lifetech Scientific (Shenzhen) Co Ltd Company Overview
- 5.21.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.22 LuSeed Vascular Company Overview
- 5.22.1 LuSeed Vascular Pipeline Products & Ongoing Clinical Trials Overview
- 5.23 Mayo Clinic Company Overview
- 5.23.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
- 5.24 Medtronic Plc Company Overview
- 5.24.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
- 5.25 Micro Interventional Devices, Inc. Company Overview
- 5.25.1 Micro Interventional Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview
- 5.26 Northwestern University Company Overview
- 5.26.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
- 5.27 Occlutech International AB Company Overview
- 5.27.1 Occlutech International AB Pipeline Products & Ongoing Clinical Trials Overview
- 5.28 SentreHEART Inc Company Overview
- 5.28.1 SentreHEART Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.29 SeptRx, Inc. (Inactive) Company Overview
- 5.29.1 SeptRx, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
- 5.30 Shanghai Shenqi Medical Technology Co Ltd Company Overview
- 5.30.1 Shanghai Shenqi Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.31 Swissimplant AG Company Overview
- 5.31.1 Swissimplant AG Pipeline Products & Ongoing Clinical Trials Overview
- 5.32 The Chaim Sheba Medical Center Company Overview
- 5.32.1 The Chaim Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview
- 5.33 University of Minnesota Company Overview
- 5.33.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
- 5.34 Vascular Closure Systems Inc Company Overview
- 5.34.1 Vascular Closure Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.35 Vascular Concepts Ltd Company Overview
- 5.35.1 Vascular Concepts Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.36 W. L. Gore & Associates Inc Company Overview
- 5.36.1 W. L. Gore & Associates Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.37 Worry Free Beating Company Overview
- 5.37.1 Worry Free Beating Pipeline Products & Ongoing Clinical Trials Overview
6 Structural Heart Occluders- Recent Developments
- 6.1 Nov 13, 2023: Jenscare : Simulock Successfully Completes Implantation Surgery for the First Confirmatory Clinical Trial
- 6.2 Oct 24, 2023: Conformal Medical Announces Compelling One-Year Data from its Left Atrial Appendage Occlusion (LAAO) Early Feasibility Study
- 6.3 Oct 17, 2023: The Gore Relief Clinical Study Begins Randomizing Patients to Evaluate PFO Closure for Migraine Headache Relief
- 6.4 Sep 07, 2023: Boston Scientific's LAAC device gets FDA approval
- 6.5 Sep 06, 2023: Boston Scientific Announces FDA Approval for the Latest-Generation WATCHMAN FLX Pro Left Atrial Appendage Closure Device
- 6.6 May 17, 2023: MicroPort's LAA closure AnchorMan device achieves primary endpoint from SAFE PROTECT clinical trial, showing very promising results
- 6.7 Feb 27, 2023: Study demonstrates successful device size selection when assessing left atrial appendage by angiography compared to TEE
- 6.8 Jan 31, 2023: Conformal Medical announces positive one-year data from its left atrial appendage closure performed under conscious sedation study
- 6.9 Jan 05, 2023: JSCAI publishes peer-reviewed article highlighting effective performance of conformal medical's Left Atrial Appendage (CLAAS) Device
- 6.10 Dec 06, 2022: Henry Ford Health to lead first-of-its-kind national trial for innovative heart device
7 Appendix
- 7.1 Methodology
- 7.2 About GlobalData
- 7.3 Contact Us
- 7.4 Disclaimer
List of Tables
List of Tables
- Structural Heart Occluders - Pipeline Products by Stage of Development
- Structural Heart Occluders - Pipeline Products by Segment
- Structural Heart Occluders - Pipeline Products by Territory
- Structural Heart Occluders - Pipeline Products by Regulatory Path
- Structural Heart Occluders - Pipeline Products by Estimated Approval Date
- Structural Heart Occluders - Ongoing Clinical Trials
- Structural Heart Occluders Companies - Pipeline Products by Stage of Development
- Structural Heart Occluders - Pipeline Products by Stage of Development
- Glossary
List of Figures
List of Figures
- Structural Heart Occluders - Pipeline Products by Stage of Development
- Structural Heart Occluders - Pipeline Products by Segment
- Structural Heart Occluders - Pipeline Products by Territory
- Structural Heart Occluders - Pipeline Products by Regulatory Path
- Structural Heart Occluders - Pipeline Products by Estimated Approval Date
- Structural Heart Occluders - Ongoing Clinical Trials
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.